Finance Manager

• Jan 2023 - Present

R&D Senior Financial Analyst

• Jan 2022 - Dec 2022

- Responsible for forecasting, consolidating, and tracking all spend for FDA mandated studies within the Discovery organization. - Preclinical studies finance lead responsible for functional budget ownership of $175M OPEX and 400 headcount. - Business partner finance support for R&D functions. - Responsible for forecasting, consolidating, and tracking all spend for FDA mandated studies within the Discovery organization. - Preclinical studies finance lead responsible for functional budget ownership of $175M OPEX and 400 headcount. - Business partner finance support for R&D functions.

Supply Chain Financial Analyst

• Feb 2021 - Jan 2022

- Creation of forecasting and reporting model that analyzes production volume and related financial information for more effective material cost data and trends. - Ownership and publishing of weekly finance metric reports for labor efficiency, material usage variance, volume, cost absorption, and headcount. - Business partner finance support for production managers, plant facilitators, and engineers. - Creation of forecasting and reporting model that analyzes production volume and related financial information for more effective material cost data and trends. - Ownership and publishing of weekly finance metric reports for labor efficiency, material usage variance, volume, cost absorption, and headcount. - Business partner finance support for production managers, plant facilitators, and engineers.

Commercial Financial Analyst

• Jun 2019 - Jan 2021

- Lead financial analyst contact for the commercial financial planning and analysis launch of Janssen COVID-19 vaccine. - Developed the financial reporting framework within Janssen for new business ventures in vaccines. - Streamlined financial planning and analysis across the Neuroscience, Infectious Diseases and Established Products Group therapeutic areas. - Business partner finance support across marketing, medical affairs, and salesforce teams. - Lead financial analyst contact for the commercial financial planning and analysis launch of Janssen COVID-19 vaccine. - Developed the financial reporting framework within Janssen for new business ventures in vaccines. - Streamlined financial planning and analysis across the Neuroscience, Infectious Diseases and Established Products Group therapeutic areas. - Business partner finance support across marketing, medical affairs, and salesforce teams.